Responses
Late-Breaking Abstracts
Combination Immunotherapies
1536 Egfl6 induces IL-10 and CXCL2 in tumor associated myeloid cells: link to anti-tumor immunosuppression and resistance to anti-PD-L1 therapy in ovarian cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
